THE TREATMENT OUTCOME OF HEPATOCELLULAR CANCER
- VernacularTitle: УЛСЫН ХОЁРДУГААР ТӨВ ЭМНЭЛЭГТ 2015-2016 ОНД ХИЙГДСЭН ЭЛЭГНИЙ АНХДАГЧ ӨМӨНГ ЭМЧИЛСЭН ЭМЧИЛГЭЭНИЙ ҮР ДҮН
- Author:
Gan-Erdene B
1
;
Chinburen J
;
Narmandakh TS
;
Altanchimeg N
;
Onon B
;
Sanchin U
;
Bilguun G
;
Ankhbayar E
;
Tuvshinbayar M
Author Information
1. Second Central Hospital of Mongolia
- Publication Type:Journal Article
- Keywords:
Hepatocellular carcinoma;
Mongolia
- From:Journal of Surgery
2016;19(1):37-40
- CountryMongolia
- Language:Mongolian
-
Abstract:
Introduction: Hepatocellular carcinoma(HCC) is the 6th most common cancer inthe world, but the first most commoncause of cancer death in Mongolia. Thereis no universally accepted consensuspractice guidelines for HCC owing to rapiddevelopments in new treatment modalities,the heterogeneous epidemiology and clinicalpresentation of HCC worldwide.Methods and Materials: This study wasconducted in the department of generalsurgery of Second Central Hospital ofMongolia between 2015 and 2016 on a totalof 36 patients with hepatocellular carcinoma.Results: The average of operationtime is a 132.2 min, the hospital stay 18.2days. Postoperative bleeding was 2.7% (1),encephalopathy 5.4% (2), wound infection5.4% (2), and incisional hernia 8.1% (3).There were not bile leak during 30 dayspostoperative day.Conclusion: Postoperative complicationis a comparable to different researcher.There were no death within first month.
